September 25, 2018
Via: Mass DevicePrivately-held Dance Biopharm said yesterday that it raised $24.5 million in a private equity round to help fund the development of its inhaled insulin product. SternAegis Ventures was the exclusive placement agent for the offering. Molex Ventures, an electronics company […]
July 9, 2024
June 25, 2024